We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva

By LabMedica International staff writers
Posted on 01 Jan 2025

Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients. More...

In approximately 20% of these cases, the condition progresses to more severe stages of AKI, leading to longer hospital stays, higher mortality rates, and an increased need for invasive renal replacement therapies. Early intervention, driven by frequent or continuous monitoring of renal function biomarkers like creatinine, could potentially delay this progression. As renal failure can advance quickly, frequent venipuncture for creatinine testing is required. Recent advances in microfluidic devices and biosensors have led to the exploration of alternative biofluids, such as sweat and saliva, for non-invasive, continuous monitoring of creatinine. Researchers have now developed a novel Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) assay for detecting low creatinine levels in these biofluids.

Researchers at Eindhoven University of Technology (Eindhoven, The Netherlandsl) investigated the correlation between creatinine concentrations in sweat, saliva, and plasma during hemodialysis, with an eye toward future biosensor applications. They measured creatinine levels in sweat, saliva, and plasma from 40 patients undergoing hemodialysis. Using the novel LC-MS/MS assay, they quantified low creatinine concentrations in these biofluids. Correlation analyses were conducted to compare creatinine levels across the biofluids. The LC-MS/MS assay demonstrated excellent accuracy (93.9% to 97.8%) and low imprecision (3.4% to 8.1%) for measuring very low creatinine concentrations, with a limit of quantitation of 1.26 µmol/L.

The study revealed strong correlations between creatinine concentrations in sweat and saliva compared to plasma (ρ: 0.68 and 0.80, respectively). During hemodialysis, creatinine concentrations declined similarly across all three biofluids. These strong correlations suggest that sweat and saliva could serve as reliable, non-invasive alternatives to traditional blood tests for assessing kidney function. This research improves the understanding of creatinine excretion pathways and lays the groundwork for the development of patient-friendly, continuous kidney function monitoring methods, such as wearable biosensors.


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
cDNA Synthesis Kit
Ultimate cDNA Synthesis Kit
New
Urine Drug Test
Instant-view® Phencyclidine Urine Drug Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Schematic overview of the deep learning-based circulating exosome analysis for lung cancer detection (Photo courtesy of Chuan Xu, Cheng Jiang)

Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer

Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more

Pathology

view channel
Image: The Aiforia Breast Cancer Grading AI solution is CE-IVD marked (Photo courtesy of Aiforia Technologies)

Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy

Labs that use traditional image analysis methods often suffer from bottlenecks and delays. By digitizing their pathology practices, labs can streamline their work, allowing them to take on larger caseloads... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.